Completed PHASE2/PHASE3 INTERVENTIONAL 4-arm NCT00715741

Does High Intraoperative Inspired Oxygen Reduce Postoperative Arterial Oxygen Saturation?

Sponsor: University of Utah

Interventions FiO2 (fraction of inspired oxygen) 0.3 plus PEEP (positive end expiratory pressure) 3 -5 cm water FiO2 0.3 without PEEP FiO2 >0.9 with 3-5 cm water PEEP FiO2 >0.9 without PEEP

Updated 8 times since 2017 Last updated: Feb 2, 2010 Started: Jun 30, 2008 Primary completion: Jul 31, 2009 Completion: Jul 31, 2009

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2/PHASE3 clinical study on Atelectasis, this trial is completed. The trial is conducted by University of Utah and has accumulated 8 data snapshots since 2008. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2/PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2/PHASE3

Phase: PHASE2_PHASE3 → PHASE2/PHASE3
Jan 2023 — Jul 2024 [monthly]

Completed PHASE2_PHASE3
Dec 2022 — Jan 2023 [monthly]

Completed PHASE2_PHASE3
Dec 2021 — Dec 2022 [monthly]

Completed PHASE2_PHASE3

▶ Show 3 earlier versions

Jan 2021 — Dec 2021 [monthly]

Completed PHASE2_PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2_PHASE3
Jan 2017 — Jun 2018 [monthly]

Completed PHASE2_PHASE3

First recorded

Jun 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University of Utah

Data source: University of Utah

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Salt Lake City, United States